Ok, so you’re using my notecards which is great. I am glad I could help you out cause I wish I had someone to help me out when I took this course. I know Anatomy is super hard.

I only ask that if you find these notecards helpful, you join Easy Notecards and create at least one notecard set to help others out. It can be for any subject or class. Thanks and don’t forget to rate my helpfulness!

ACTIVITY 2:
EXPLAIN WHY THYROXINE HAD THESE EFFECTS.

THYROXINE IS THE MOST IMPORTANT HORMONE IN MAINTAINING METABOLISM AND BODY HEAT.

ACTIVITY 3:
WAS THERE A CHANGE IN THE METABOLIC RATE OF THE THYROIDECTOMIZED RAT WITH THE ADMINISTRATION OF TSH? EXPLAIN YOUR RESULTS.

IT INCREASED BUT HARDLY AT ALL. IF THE RAT HAS NO THYROID THE TSH IS NOT GOING TO STIMULATE ANYTHING, SO THYROXINE WONT BE RELEASED AND THERE WAS HARDLY NO CHANGE.

ACTIVITY 3:
DID THE RESULTS OR THE THYROIDECTOMIZED RAT INDICATE HYPERTHYROIDISM OR HYPOTHYROIDISM?

IT INDICATED HYPOTHYROIDISM

ACTIVITY 4:
DESCRIBE THE EFFECT OF ADMINISTERING PROPYLTHIOURACIL ON EACH OF THE RATS, AND EXPLAIN WHY IT HAD THIS EFFECT.

THE EFFECT OF PROPYLTHIOURACIL ON THE RATS MADE THE METABOLIC RATES REMAIN LOW. THIS IS BECAUSE PROPYLTHIOURACIL INHIBITS THYROXINE. SO THYROXINE IS NOT STIMULATED IN ANY RAT AND THE RATS THEREFORE CAN NOT MAINTAIN METABOLISM AND BODY HEAT MAKING NO CHANGE IN THE RATES.

ACTIVITY 4:
DO YOU THINK THE DRUG PROPYLTHIOURACIL IS USED TO TREAT HYPOTHYROIDISM OR HYPERTHYROIDISM? EXPLAIN YOUR ANSWER.

IT IS USED TO TREAT HYPERTHYROIDISM. SINCE IT INHIBITS THYROXINE IT CAN BE USED TO CONTROL THYROID PRODUCTION OF THYROXINE, AND FURTHER CONTROL HYPERTHYROIDISM.

ACTIVITY 5:
EXPLAIN WHY OVARIECTOMIZED RATS WERE USED IN THIS EXPERIMENT AND CORRELATE THIS TO THEIR BASELINE T SCORE.

THREE OVARIECTOMIZED RATS WERE USED BECASUE THEY ARE NO LONGER PRODUCING ESTROGEN DUE TO THE REMOVAL OF THEIR OVARIES. BECAUSE ESTROGEN IS NOT BEING PRODUCED MENOPAUSE STARTED AND THE RESULT WAS OSTEOPOROSIS WITH THE BASELINE T SCORE AT -2.6

ACTIVITY 5:
RECAP YOUR PREDICTIONS REGARDING THE EFFECTS OF CALCITONIN AND ESTROGEN ON BONE DENSITY AND EXPLAIN WHY YOU MADE THOSE PREDICTIONS.

I PREDICTED THAT THEY WOULD BOTH IMPROVE THE BONE DENSITY. BECAUSE ADMINISTRATING ESTROGEN OR CALCITONIN ARE FORMS OF HORMONE REPLACEMENT THERAPY. ESTROGEN WILL INCREASE BONE DENSITY AND CALCITONIN WILL INHIBIT OSTEOCLAST ACTIVITY AND STIMULATE CALCIUM UPTAKE FOR DEPOSIT IN BONE.

ACTIVITY 5:
WHY WAS ONE OF THE OVERIECTOMIZED RATS INJECTED WITH SALINE?

THIS IS THE CONTROLLED PORTION OF THE EXPERIMENT SINCE SALINE IS JUST SALT AND WATER IT WOULDN'T CASE ANY AFFECT ON THE RAT.

ACTIVITY 5:
WHAT EFFECT DID THE ADMINISTRATION OF ESTROGEN INJECTIONS HAVE ON THE ESTROGEN-TREATED RAT?

IT IMPROVED BONE DENSITY FROM -2.6 OSTEOPOROSIS TO -1.9 OSTEOPENIA.

ACTIVITY 5:
WHAT EFFECT DID THE ADMINISTRATION OF CALCITONIN INJECTIONS HAVE ON THE CALCITONIN-TREATED RATS?

IT IMPROVED BONE DENSITY FROM -2.6 OSTEOPOROSIS TO -2.47 OSTEOPENIA; ALTHOUGH IT WAS NOT A BIG DIFFERENCE THE LEVELS IN CLASSIFICATION ARE DIFFERENT.

ACTIVITY 5:
HOW DID YOUR RESULTS COMPARE TO YOUR PREDICTIONS?

MY PREDICTIONS WERE RIGHT, ALTHOUGH I THOUGHT THERE WOULD BE A GREATER IMPROVEMENT.

ACTIVITY 6:
WHAT IS A GLUCOSE STANDARD CURVE AND HOW CAN YOU USE THIS TOOL TO DETERMINE A CONCENTRATION OF GLUCOSE?

THE GLUCOSE STANDARD CURVE GIVES THE POINT OF REFERENCE FOR CONVERTING OPTICAL DENSITY READINGS. YOU CAN USE THIS TOOL TO DETERMINE THE CONCENTRATION OF GLUCOSE BY USING A SPECTROPHOTOMETER TO DETERMINE HOW MUCH GLUCOSE IS PRESENT IN A BLOOD SAMPLE.

ACTIVITY 7:
WHICH PATIENT(S) HAD GLUCOSE READING(S) IN THE NORMAL RANGE?

PATIENT 1 (TUBE 1) HAD A READING OF 101MG/DL, WAY BELOW 110 MG/DL SO IT FALLS IN THE NORMAL RANGE.

ACTIVITY 7:
WHICH PATIENT(S) HAD GLUCOSE READING(S) IN THE DIABETIC RANGE?

PATIENTS 3 AND 5 HAD GLUCOSE READING IN THE DIABETIC RANGE.

ACTIVITY 7:
WHICH PATIENT(S) HAD GLUCOSE READING(S) IN THE IMPAIRED RANGE?

PATIENTS 2 AND 4 HAD GLUCOSE READINGS IN THE IMPAIRED OR BORDERLINE IMPARIMENT RANGE.

ACTIVITY 7:
DESCRIBE THE DIAGNOSIS FOR PATIENT 3.

TYPE 2 DIABETES MELLITUS - GLUCOSE REMAINS IN BLOODSTREAM UNABLE TO BE TAKEN UP BY THE BODY'S CELLS TO SERVE AS THE PRIMARY FUEL FOR METABOLISM.

ACTIVITY 8:
WHICH PATIENT WOULD MOST LIKELY BE DIAGNOSED WITH CUSHING'S DISEASE? WHY?

PATIENT 3; BECAUSE HYPERCORTISOLISM CAUSED BY A PITUITARY TUMOR ALSO CAUSES LEVELS OF ACTH TO INCREASE, THIS PATIENT HAS BOTH THESE LEVELS HIGH SO IS MORE THEN LIKELY TO HAVE CUSHING'S DISEASE.

ACTIVITY 8:
WHICH TWO PATIENT'S HAVE HORMONE LEVELS CHARACTERISTIC OF CUSHING'S SYNDROME?

PATIENT 2 AND 5 HAVE HORMONE LEVELS THAT ARE SIMILAR TO THOSE OF CUSHING'S SYNDROME.

ACTIVITY 8:
PATIENT 2 IS BEING TREATED FOR RHEUMATOID ARTHRITIS WITH PREDNISONE. HOW DOES THIS CHANGE THE DIAGNOSIS?

ITS NOT CUSHING'S SYNDROME IF ITS IATROGENIC (PHYSICIAN INDUCED). THE PATIENT DOES NOT NORMALLY HAVE CUSHING'S SYNDROME AND ITS PURPOSELY POSSIBLY A TEMPORARY TREATMENT THAT WHEN IT STOPS BEING INDUCED MIGHT BE CORRECTED AGAIN.

ACTIVITY 8:
WHICH PATIENT WOULD MOST LIKELY BE DIAGNOSED WITH ADDISON'S DISEASE? WHY?

PATIENT 4 WOULD MOST LIKELY BE DIAGNOSED WITH ADDISON'S DISEASE. THE PATIENT HAS LOW CORTISOL BUT ACTH LEVELS WERE HIGH. IN THIS DISEASE THE LOW CORTISOL IS DIRECTLY DUE TO GRADUAL DESTRUCTION OF THE ADRENAL CORTEX, AND ACTH LEVELS ARE TYPICALLY ELEVATED AS A COMPENSATORY EFFECT.